The company has developed a number of digital marketing tools that lay the foundations for a competitive suite of digital marketing solutions.
's () director Damon Rasheed has demonstrated his confidence in the company's digital healthcare strategy through the on-market purchase of 4 million shares at 2 cents per share.
The non-executive director's $8,000 transaction on October 15 represents his first purchase of fully paid ordinary shares in the company.
Earlier this year ShareRoot completed a restructure and has a clear path forward to a successful business in the digital healthcare industry.
Completion of capital raising
The company recently raised a total of $1,289,612 which included a rights issue and placement.
Funds raised were allocated for the following:
- To scale the existing revenue-generating digital client services capabilities and capacity;
- To complete and launch new technology products and roll-out campaigns;
- To continue development of MediaConsent Clinical; and
- To reposition the company within the target market.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Opyl Ltd named herein, including the promotion by the Company of Opyl Ltd in any Content on the Site, the Company receives from said issuer...
FOR OUR FULL DISCLAIMER CLICK HERE